Advances in immunology: Complement (second of two parts)

New England Journal of Medicine

Volumn 344, Issue 15, 2001, Pages 1140-1144

  Walport, Mark J ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; IMMUNOGLOBULIN M;

ANTIBODY RESPONSE; ANTIGEN ANTIBODY COMPLEX; APOPTOSIS; CELL DEATH; COMPLEMENT ACTIVATION; COMPLEMENT DEFICIENCY; COMPLEMENT SYSTEM; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; IMMUNOLOGY; INFLAMMATION; NECROSIS;

ANIMALS; ANTIGEN-ANTIBODY COMPLEX; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM PROTEINS; HUMANS; IMMUNOGLOBULIN M; INFLAMMATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; NECROSIS;

EID: 0035849176     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200104123441506     Document Type: Review

References (35)

1. The role of complement in B cell activation and tolerance
2. Role of complement in induction of the allergic response
3. Role of complement in induction of antibody production in vivo: Effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses
4. Activation of B lymphocytes: Integrating signals from CD19, CD22 and Fc gamma RIIb1
5. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity
6. Natural autoantibodies
7. Innate and acquired humoral immunities to influenza virus are mediated by distinct arms of the immune system
8. Regulation of antibody responses via antibodies, complement, and Fc receptors
9. A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection
10. Cardiolipin-protein complexes and initiation of complement activation after coronary artery occlusion
11. Inflammation in the course of early myocardial ischemia
12. Complement activation after oxidative stress: Role of the lectin complement pathway
13. Intestinal reperfusion injury is mediated by IgM and complement
14. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction
15. Recombinant soluble CR1 suppressed complement activation, inflammation, and necrosis associated with reperfusion of ischemic myocardium
16. Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein
17. Therapeutic inhibition of the complement system
18. Cl-esterase inhibitor: An anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema
19. Systemic lupus erythematosus, complement deficiency, and apoptosis
20. Essentielle hypokomplementämie
21. A revised estimate of twin concordance in systemic lupus erythematosus
22. Lupus-erythematosus-like disease in three unrelated women with hereditary angioneurotic edema
23. Complement deficiency and immune complex disease
24. Clq binds directly and specifically to surface blebs of apoptotic human keratinocytes: Complement deficiency and systemic lupus erythematosus revisited
25. C-reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: Implications for systemic autoimmunity
26. Complement-dependent clearance of apoptotic cells by human macrophages
27. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo
28. Serum amyloid P component binds to cell nuclei in vitro and to in vivo deposits of extracellular chromatin in systemic lupus erythematosus
29. Amyloid P component binds to keratin bodies in human skin and to isolated keratin filament aggregates in vitro
30. Serum amyloid P component controls chromatin degradation and prevents antinuclear auto-immunity
31. Features of systemic lupus erythematosus in Dnase 1-deficient mice
32. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM
33. Deficiency in serum immunoglobulin (Ig)M predisposes to development of IgG autoantibodies
34. Autoantibodies against Clq: View on clinical relevance and pathogenic role
35. Complement-activating complex of ficolin and mannose-binding lectin-associated serine protease